サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1463657

北米の脳脊髄液管理：2030年までの市場予測 - 地域分析 - 製品別、エンドユーザー別

North America Cerebrospinal Fluid Management Market Forecast to 2030 - Regional Analysis - by Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)

出版日
ページ情報
英文 80 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
北米の脳脊髄液管理：2030年までの市場予測 - 地域分析 - 製品別、エンドユーザー別
出版日: 2024年01月22日
発行: The Insight Partners
ページ情報: 英文 80 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の脳脊髄液管理市場は、2022年に8億796万米ドルと評価され、2030年には12億4,249万米ドルに達すると予測され、2022年から2030年までのCAGRは5.5%と推定されます。

脳脊髄液漏出症例の増加が北米の脳脊髄液管理市場を後押し

Journal of Neurosurgeryによると、世界では年間6,900万人以上が外傷性脳損傷に苦しんでいると推定されています。脳や脊髄の損傷は、成人の脳脊髄液（CSF）漏れの最も一般的な原因であり、CSF管理が必要となります。ライフスタイルの変化や不健康な生活習慣が主な原因である高血圧も、成人や高齢者における髄液漏れの顕著な原因です。同様に、高血圧は高齢者に多く、最終的には特発性頭蓋内圧亢進症（IIH）のリスクを高めることになります。したがって、老年人口の増加は北米の脳脊髄液管理市場の成長に関連する可能性があります。

水頭症の発生率は世界中で著しく増加しています。水頭症の発生率は老年人口で最も高く、特に小児人口では成人に比べて高いです。米国国立医学図書館（NLM）が発表した論文によると、水頭症の世界の有病率は10万人あたり約85人です。同じ出典によると、小児における有病率は10万人あたり88人であるのに対し、成人では10万人あたり11人、老人では10万人あたり175人です。さらに、低・中所得国の水頭症罹患率は出生10万人当たり123人であるのに対し、高所得国では79人です。髄液シャントとドレナージシステムは、あらゆる年齢層の水頭症例に適した治療法です。したがって、髄液漏れの症例の増加が北米の脳脊髄液管理市場の成長を後押ししています。

北米の脳脊髄液管理市場の概要

北米の脳脊髄液管理市場は米国、カナダ、メキシコに区分されます。この地域では米国が最大のシェアを占めています。この地域の市場は、水頭症、外傷性脳損傷、その他の神経疾患の発生率の増加、急速な技術革新、新興国市場のインフラ整備などにより、予測期間中も優位を保つと予想されます。

北米の脳脊髄液管理市場の収益と2030年までの予測（US$Mn）

北米の脳脊髄液管理市場のセグメンテーション

北米の脳脊髄液管理市場は、製品、エンドユーザー、国に区分されます。

製品別では、北米の脳脊髄液管理市場はCSFシャントとCSFドレナージシステムに二分されます。2022年にはCSFシャントセグメントが大きな市場シェアを占めています。

エンドユーザー別に見ると、北米の脳脊髄液管理市場は病院、クリニック、外来手術センター、その他に区分されます。病院セグメントが2022年に最大の市場シェアを占めました。

国別では、北米の脳脊髄液管理市場は米国、カナダ、メキシコに区分されます。米国が2022年の北米の脳脊髄液管理市場シェアを独占しました。

Argi Group Health Services Ltd Sti、B. Braun SE、BeckerSmith Medical Inc、Integra LifeSciences Holdings Corp、Medtronic Plc、Natus Medical Inc、Sophysa SA、Spiegelberg GmbH &Co KGは、北米の脳脊髄液管理市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の脳脊髄液管理市場の情勢

  • 北米のPEST分析

第5章 北米の脳脊髄液管理市場- 主要産業力学

  • 市場促進要因
    • 脳脊髄液漏出症例の増加
    • 髄液管理製品の開発
  • 市場抑制要因
    • 故障や誤作動のリスク
  • 市場機会
    • 神経疾患治療における髄液管理への注目の高まり
  • 今後の動向
    • スマート脳脊髄液シャントの開発
  • 影響分析

第6章 脳脊髄液管理市場-北米市場分析

  • 北米の脳脊髄液管理市場収益、2022年～2030年

第7章 北米の脳脊髄液管理市場 - 収益と2030年までの予測：製品別

  • 市場収益シェア、2022年および2030年
  • 髄液シャント
  • 髄液ドレナージシステム

第8章 北米の脳脊髄液管理市場 - 収益と2030年までの予測：エンドユーザー別

  • 市場収益シェア、2022年および2030年
  • 病院
  • 診療所
  • 外来手術センター
  • その他

第9章 北米の脳脊髄液管理市場：国別分析

  • 北米の脳脊髄液管理市場：国別
  • 米国
  • カナダ
  • メキシコ

第10章 北米の脳脊髄液管理市場：業界情勢

  • 北米の脳脊髄液管理市場における成長戦略、2020～2023年
  • 無機的成長戦略
  • 有機的成長戦略

第11章 企業プロファイル

  • Medtronic Plc
  • Integra LifeSciences Holdings Corp
  • B. Braun SE
  • Argi Group Health Services Ltd Sti
  • Sophysa SA
  • BeckerSmith Medical Inc
  • Natus Medical Inc
  • Spiegelberg GmbH & Co KG

第12章 付録

図表

List Of Tables

  • Table 1. North America Cerebrospinal Fluid Management Market Segmentation
  • Table 2. US: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 3. US: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 4. US: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 5. US: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 6. Canada: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 7. Canada: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 8. Canada: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 9. Canada: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 10. Mexico: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 11. Mexico: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 12. Mexico: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 13. Mexico: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 14. Recent Inorganic Growth Strategies in the North America Cerebrospinal Fluid Management Market
  • Table 15. Recent Organic Growth Strategies in The North America Cerebrospinal Fluid Management Market
  • Table 16. Glossary of Terms, North America Cerebrospinal Fluid Management Market

List Of Figures

  • Figure 1. North America Cerebrospinal Fluid Management Market Segmentation, By Country
  • Figure 2. North America - PEST Analysis
  • Figure 3. North America Cerebrospinal Fluid Management Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. North America Cerebrospinal Fluid Management Market Revenue, Country (US$ Mn), 2022 - 2030
  • Figure 7. North America Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 8. CSF Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Ventriculoperitoneal Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Ventriculoatrial Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Ventriculopleural Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Lumboperitoneal Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. CSF Drainage Systems: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. External Ventricular Drainage (EVD) Systems: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Lumbar Drainage (LD) Systems: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. North America Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 17. Hospitals: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Clinics: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Ambulatory Surgical Centers: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Others: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. North America Cerebrospinal Fluid Management Market, by Key Country- Revenue (2022) ($Mn)
  • Figure 22. North America Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
  • Figure 23. US: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. Canada: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Mexico: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Growth Strategies in The North America Cerebrospinal Fluid Management Market, 2020-2023
目次
Product Code: TIPRE00028003

The North America cerebrospinal fluid management market was valued at US$ 807.96 million in 2022 and is expected to reach US$ 1,242.49 million by 2030; it is estimated to grow at a CAGR of 5.5% from 2022 to 2030.

Increasing Cases of Cerebrospinal Fluid Leaks Fuels the North America Cerebrospinal Fluid Management Market

According to the Journal of Neurosurgery, more than 69 million people globally are estimated to suffer from traumatic brain injuries annually. Brain and spinal injuries are the most common causes of cerebrospinal fluid (CSF) leaks in adults, necessitating CSF management. High blood pressure, majorly caused due to a shift in lifestyle and unhealthy habits, is another notable cause of CSF leaks among adults and elderlies. Similarly, high blood pressure is common in elderly people, which ultimately leads to an increasing risk of idiopathic intracranial hypertension (IIH). Thus, the growing geriatric population can be associated with the growth of the North America cerebrospinal fluid management market.

The incidence of hydrocephalus is growing significantly across the world. The occurrence of hydrocephalus is highest in the geriatric population; notably, it is higher in the pediatric population compared to adults. According to an article published by the National Library of Medicine (NLM), the global prevalence of hydrocephalus is ~85 per 100,000 individuals. Per the same source, the prevalence rate in the pediatric population is ~88 per 100,000 whereas the rate is ~11 per 100,000 in adults and ~175 per 100,000 in the geriatric population. Further, the incidence rate of hydrocephalus in low- and medium-income countries is ~123 per 100,000 births whereas the rate in high-income countries is 79 per 100,000 births. The CSF shunts and drainage systems are the treatment options suitable for hydrocephalus cases diagnosed in people from all age groups. Hence, an increase in CSF leak cases boosts the growth of the North America cerebrospinal fluid management market.

North America Cerebrospinal Fluid Management Market Overview

The North America cerebrospinal fluid management market is segmented into the US, Canada, and Mexico. The US held the largest share of the market in this region. The market in this region is expected to continue its dominance during the forecast period due to the increasing hydrocephalus, traumatic brain injury, and other neurological condition incidences; rapid technological innovations; and developing healthcare infrastructure.

North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)

North America Cerebrospinal Fluid Management Market Segmentation

The North America cerebrospinal fluid management market is segmented into product, end user and country.

Based on product, the North America cerebrospinal fluid management market is bifurcated into CSF shunts and CSF drainage systems. The CSF shunts segment held a larger market share in 2022.

Based on end user, the North America cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022.

Based on country, the North America cerebrospinal fluid management market is segmented into the US, Canada, and Mexico. The US dominated the North America cerebrospinal fluid management market share in 2022.

Argi Group Health Services Ltd Sti, B. Braun SE, BeckerSmith Medical Inc, Integra LifeSciences Holdings Corp, Medtronic Plc, Natus Medical Inc, Sophysa SA, and Spiegelberg GmbH & Co KG are some of the leading companies operating in the North America cerebrospinal fluid management market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Cerebrospinal Fluid Management Market Landscape

  • 4.1 Overview
  • 4.2 North America PEST Analysis

5. North America Cerebrospinal Fluid Management Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Cases of Cerebrospinal Fluid Leaks
    • 5.1.2 Developments in CSF Management Products
  • 5.2 Market Restraints
    • 5.2.1 Risk of Failure and Malfunctioning
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Focus on CSF Management in Neurological Disease Treatments
  • 5.4 Future Trends
    • 5.4.1 Development of Smart Cerebrospinal Fluid Shunts
  • 5.5 Impact Analysis:

6. Cerebrospinal Fluid Management Market - North America Market Analysis

  • 6.1 North America Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030

7. North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 North America Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 CSF Shunts
    • 7.3.1 Overview
    • 7.3.2 CSF Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.3 Ventriculoperitoneal Shunts
      • 7.3.3.1 Overview
      • 7.3.3.2 Ventriculoperitoneal Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.4 Ventriculoatrial Shunts
      • 7.3.4.1 Overview
      • 7.3.4.2 Ventriculoatrial Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.5 Ventriculopleural Shunts
      • 7.3.5.1 Overview
      • 7.3.5.2 Ventriculopleural Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.6 Lumboperitoneal Shunts
      • 7.3.6.1 Overview
      • 7.3.6.2 Lumboperitoneal Shunts: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 CSF Drainage Systems
    • 7.4.1 Overview
    • 7.4.2 CSF Drainage Systems: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.3 External Ventricular Drainage (EVD) Systems
      • 7.4.3.1 Overview
      • 7.4.3.2 External Ventricular Drainage (EVD) Systems: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.4 Lumbar Drainage (LD) Systems
      • 7.4.4.1 Overview
      • 7.4.4.2 Lumbar Drainage (LD) Systems: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by End User

  • 8.1 Overview
  • 8.2 North America Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
  • 8.3 Hospitals
    • 8.3.1 Overview
    • 8.3.2 Hospitals: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Clinics
    • 8.4.1 Overview
    • 8.4.2 Clinics: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Ambulatory Surgical Centers
    • 8.5.1 Overview
    • 8.5.2 Ambulatory Surgical Centers: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: North America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Cerebrospinal Fluid Management Market - Country Analysis

  • 9.1 Overview
      • 9.1.1.1 North America Cerebrospinal Fluid Management Market, by Country
      • 9.1.1.2 US
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 US: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.2.3 US: North America Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.2.3.1 US: North America Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.2.3.2 US: North America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.2.4 US: North America Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.3 Canada
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 Canada: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.3.3 Canada: North America Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.3.3.1 Canada: North America Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.3.3.2 Canada: North America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.3.4 Canada: North America Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.4 Mexico
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 Mexico: North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.4.3 Mexico: North America Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.4.3.1 Mexico: North America Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.4.3.2 Mexico: North America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.4.4 Mexico: North America Cerebrospinal Fluid Management Market, by End User

10. North America Cerebrospinal Fluid Management Market -Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in The North America Cerebrospinal Fluid Management Market, 2020-2023
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Medtronic Plc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Integra LifeSciences Holdings Corp
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 B. Braun SE
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Argi Group Health Services Ltd Sti
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Sophysa SA
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 BeckerSmith Medical Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Natus Medical Inc
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Spiegelberg GmbH & Co KG
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms